Planning for SAT exam 2026? Learn the SAT full form, why SAT matters for college admissions, when to take it, and facts about ...
Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...
Resilient leaders recognize that success is a direct result of getting up again after failure. And that starts with the ...
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by using a patient’s own T-cells to target tumors. However, they can cause rare but potentially fatal cardiac inflammation ...
Small interfering RNAs (siRNAs) are widely used to study gene function and there is general excitement about their potential for therapeutic applications. However, several hurdles, including a lack of ...
The concept of saline nasal irrigation, or bathing the nasal passages with a saltwater solution, is thought to have been ...
FTX, the latest Fraxel upgrade, is non-ablative and uses the same dual-wavelength technology (1550–1927 nm) as its ...
An artificial saliva in the form of a mouthwash, produced with the CANECPI-5 protein extracted from sugarcane and modified in ...
The first-in-human clinical study of SRP-1005, known as INSIGHTT, is expected to begin in the second quarter of 2026CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the ...
Uthmeier is also backing 2026 bills to strengthen penalties for illegal gambling and related advertising, both online and in ...
FDA grants AXS-05 Priority Review designation and sets PDUFA action goal date of April 30, 2026NEW YORK, (GLOBE NEWSWIRE) -- ...
GenEditBio Limited ('GenEditBio'), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. Food and Drug Administration (FDA) has cleared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback